Abstract
Introduction
Influenza infection poses a significant public health threat. The core for disease prevention and control relies on strengthened surveillance activities, particularly in Saudi Arabia, the country that hosts the largest annual mass gathering event worldwide. This study aimed to assess the molecular and seasonal pattern of influenza virus subtypes in western Saudi Arabia to inform policy decisions on influenza vaccine.
Methods
This cross-sectional study was conducted at King Abdulaziz Medical City, western Saudi Arabia. Medical records and surveillance database of laboratory-confirmed influenza cases were reviewed from October 2015 to 2019. A panel of real-time polymerase chain reactions was performed to detect influenza A and B. Extracted RNA from a subset of positive samples was used to determine influenza A subtypes and influenza B lineages.
Results
This study included a total of 1928 patients with laboratory-confirmed influenza infections. Influenza peaks were observed in October each season, with variant predominant strains. Influenza virus subtypes co-circulate with no reports of co-infection. Influenza A(H3N2) was reported in 42% of the cases, then influenza B (30.7%) and influenza A(H1N1)pdm09 (27.3%). Healthcare workers represented 9.4% of the cases. One-third of the cases (30.4%) were admitted to the hospital with a median admission duration of 4 days. The influenza B viruses were subtyped in 218 cases. Victoria lineage was predominant (64.1%) in 2015 and 2016; however, Yamagata was predominant in the next two consecutive seasons (94.4% and 85.4%, respectively).
Conclusion
The burden due to influenza B may be underestimated with an observed vaccine mismatch. A quadrivalent influenza vaccine is recommended to reduce the health impact associated with influenza B infections. Molecular surveillance of the influenza viruses should be enhanced continuously for a better understanding of the influenza activity and assessment of vaccine effectiveness.
Article PDF
Avoid common mistakes on your manuscript.
References
Paules C, Subbarao K. Influenza. Lancet 2017;390;697–708.
Thompson CI, Barclay WS, Zambon MC. Changes in in vitro susceptibility of influenza A H3N2 viruses to a neuraminidase inhibitor drug during evolution in the human host. J Antimicrob Chemother 2004;53;759–65.
Rota PA, Hemphill ML, Whistler T, Regnery HL, Kendal AP. Antigenic and genetic characterization of the haemagglutinins of recent cocirculating strains of influenza B virus. J Gen Virol 1992;73;2737–42.
Yoon SW, Webby RJ, Webster RG. Evolution and ecology of influenza A viruses. In: Compans R, Oldstone M, editors. Influenza Pathogenesis and Control - Volume I. Current Topics in Microbiology and Immunology. Switzerland: Springer, Cham; 2014, pp. 359–75.
Chen R, Holmes EC. The evolutionary dynamics of human influenza B virus. J Mol Evol 2008;66;655–63.
Ali G, Amer HM, Almajhdi FN. Hemagglutinin and neuraminidase genes of influenza B viruses circulating in Riyadh, Saudi Arabia during 2010-2011: evolution and sequence analysis. J Med Virol 2014;86;1003–16.
Nerome R, Hiromoto Y, Sugita S, Tanabe N, Ishida M, Matsumoto M, et al. Evolutionary characteristics of influenza B virus since its first isolation in 1940: dynamic circulation of deletion and insertion mechanism. Arch Virol 1998;143;1569–83.
McCullers JA, Wang GC, He S, Webster RG. Reassortment and insertion-deletion are strategies for the evolution of influenza B viruses in nature. J Virol 1999;73;7343–8.
Shaw M, Cooper L, Xu X, Thompson W, Krauss S, Guan Y, et al. Molecular changes associated with the transmission of avian influenza A H5N1 and H9N2 viruses to humans. J Med Virol 2002;66;107–14.
Chi XS, Bolar T V, Zhao P, Tam JS, Rappaport R, Cheng SM. Molecular evolution of human influenza A/H3N2 virus in Asia and Europe from 2001 to 2003. J Clin Microbiol 2005;43;6130–2.
Wie SH, So BH, Song JY, Cheong HJ, Seo YB, Choi SH, et al. A comparison of the clinical and epidemiological characteristics of adult patients with laboratory-confirmed influenza A or B during the 2011-2012 influenza season in Korea: a multi-center study. PLoS One 2013;8;e62685.
Dawood FS, Fiore A, Kamimoto L, Bramley A, Reingold A, Gershman K, et al. Burden of seasonal influenza hospitalization in children, United States, 2003 to 2008. J Pediatr 2010;157; 808–14.
Bakir TMF, Halawani M, Ramia S. Viral aetiology and epidemiology of acute respiratory infections in hospitalized Saudi children. J Trop Pediatr 1998;44;100–3.
Al-Shehri MA, Sadeq A, Quli K. Bronchiolitis in Abha, Southwest Saudi Arabia: viral etiology and predictors for hospital admission. West Afr J Med 2005;24;299–304.
Rashid H, Shafi S, Haworth E, Memish ZA, El Bashir H, Ali KA, et al. Influenza vaccine in Hajj pilgrims: policy issues from field studies. Vaccine 2008;26;4809–12.
Almajhdi FN, Ali G. Report on influenza A and B viruses: their coinfection in a saudi leukemia patient. Biomed Res Int 2013;2013;290609.
World Health Organization. WHO information for the molecular detection of influenza viruses. Geneva, Switzerland: WHO; 2017. Available from: https://www.who.int/influenza/gisrs_laboratory/WHO_information_for_the_molecular_detection_of_influenza_viruses_20171023_Final.pdf.
Elhakim M, Hafiz Rasooly M, Fahim M, Sheikh Ali S, Haddad N, Cherkaoui I, et al. Epidemiology of severe cases of influenza and other acute respiratory infections in the Eastern Mediterranean Region, July 2016 to June 2018. J Infect Public Health 2020;13;423–9.
Khan W, El Rifay AS, Malik M, Kayali G. Influenza research in the eastern mediterranean region: a review. Oman Med J 2017;32;359–64.
Malik M, Mahjour J, Khan W, Alwan A. Influenza in the Eastern Mediterranean region: identifying the unknowns for detection and control of epidemic and pandemic threats. East Mediterr Health J 2016;22;428–9.
Al Khatib HA, Al Thani AA, Gallouzi I, Yassine HM. Epidemiological and genetic characterization of pH1N1 and H3N2 influenza viruses circulated in MENA region during 2009– 2017. BMC Infect Dis 2019;19;314.
Horton KC, Dueger EL, Kandeel A, Abdallat M, El-Kholy A, Al-Awaidy S, et al. Viral etiology, seasonality and severity of hospitalized patients with severe acute respiratory infections in the Eastern Mediterranean Region, 2007–2014. PLoS One 2017;12;e0180954.
Caini S, El-Guerche Séblain C, Ciblak MA, Paget J. Epidemiology of seasonal influenza in the Middle East and North Africa regions, 2010–2016: circulating influenza A and B viruses and spatial timing of epidemics. Influenza Other Respir Viruses 2018;12;344–52.
Yezli S, Assiri AM, Alhakeem RF, Turkistani AM, Alotaibi B. Meningococcal disease during the Hajj and Umrah mass gatherings. Int J Infect Dis 2016;47;60–4.
World Health Organization. Influenza. Vaccination timing. 2017. Available from: http://www.who.int/influenza/vaccines/tropics/ vaccination_timing/en/ (accessed February 25, 2020).
Camilloni B, Neri M, Lepri E, Iorio AM. Cross-reactive antibodies in middle-aged and elderly volunteers after MF59-adjuvanted subunit trivalent influenza vaccine against B viruses of the B/Victoria or B/Yamagata lineages. Vaccine 2009;27;4099–103.
Levandowski RA, Regnery HL, Staton E, Burgess BG, Williams MS, Groothuis JR. Antibody responses to influenza B viruses in immunologically unprimed children. Pediatrics 1991;88;1031–6.
Author information
Authors and Affiliations
Corresponding author
Additional information
Data availability statement: The authors confirm that the data supporting the findings of this study are available within the article.
Rights and permissions
This is an open access article distributed under the CC BY-NC 4.0 license (http://creativecommons.org/licenses/by-nc/4.0/).
About this article
Cite this article
Althaqafi, A., Farahat, F., Alsaedi, A. et al. Molecular Detection of Influenza A and B Viruses in Four Consecutive Influenza Seasons 2015–16 to 2018–19 in a Tertiary Center in Western Saudi Arabia. J Epidemiol Glob Health 11, 208–215 (2021). https://doi.org/10.2991/jegh.k.210427.001
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.2991/jegh.k.210427.001